Variation in microbial identification system accuracy for yeast identification depending on commercial source of Sabouraud dextrose agar

Journal of Clinical Microbiology

Volumn 37, Issue 6, 1999, Pages 2080-2083

  Kellogg, James A ^a   Bankert, David A ^a   Chaturvedi, Vishnu ^b  

^a YORK HOSPITAL   (United States)

^b NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIAGNOSTIC ACCURACY; FUNGUS CULTURE; FUNGUS IDENTIFICATION; LABORATORY TEST; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENCE;

FUNGI;

EID: 0032959760     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.6.2080-2083.1999     Document Type: Article

References (26)

1. Becton Dickinson Microbiology Systems. 1997. Quality control/product information. Sabouraud dextrose agar. P21180. Becton Dickinson Microbiology Systems, Cockeysville, Md.
2. Birnbaum, D., L. Herwaldt, D. E. Low, M. Noble, M. Pfaller, R. Sherertz, and A. W. Chow. 1994. Efficacy of Microbial Identification System for epidemiologic typing of coagulase-negative staphylococci. J. Clin. Microbiol. 32:2113-2119.
3. Blinkhorn, R. J., D. Aldelstein, and P. J. Spagnuolo. 1989. Emergence of a new opportunistic pathogen, Candida lusitaniae. J. Clin. Microbiol. 27:236-240.
4. Body, G. P. 1992. Azole antifungal agents. Clin. Infect. Dis. 14(Suppl.):161-169.
5. Christenson, J. C., A. Guruswamy, G. Mukwaya, and P. J. Rettig. 1987. Candida lusitaniae: an emerging human pathogen. Pediatr. Infect. Dis. J. 6:755-757.
6. Crist, A. E., Jr., L. M. Johnson, and P. J. Burke. 1996. Evaluation of the Microbial Identification System for the identification of clinically isolated yeasts. J. Clin. Microbiol. 34:2408-2410.
7. Dooley, D. P., M. L. Beckius, and B. S. Jeffrey. 1994. Misidentification of clinical yeast isolates by using the updated Vitek Yeast Biochemical Card. J. Clin. Microbiol. 32:2889-2892.
8. El-Zaatari, M., L. Pasarell, M. R. McGinnis, J., Buckner, G. A. Land, and I. F. Salkin. 1990. Evaluation of the updated Vitek yeast identification database. J. Clin. Microbiol. 28:1938-1941.
9. Fenn, J. P., H. Segal, B. Barland, D. Denton, J. Whisenant, H. Chun, K. Christofferson, L. Hamilton, and K. Carroll. 1994. Comparison of updated Vitek Yeast Biochemical Card and API 20C yeast identification systems. J. Clin. Microbiol. 32:1184-1187.
10. Gray, L. D., and G. D. Roberts. 1988. Identification of medically important yeasts. Clin. Microbiol. Newsl. 10:73-77.
11. Hazen, K. C. 1995. New and emerging yeast pathogens. Clin. Microbiol. Rev. 8:462-178.
12. Kellogg, J. A., D. A. Bankert, T. M. Brenneman, M. A. Grove, S. L. Wetzel, and K. S. Young. 1996. Identification of clinical isolates of non-Enterobacteriaceae gram-negative rods using computer-assisted gas-liquid chromatography. J. Clin. Microbiol. 34:1003-1006.
13. Kellogg, J. A., D. A. Bankert, and V. Chaturvedi. 1998. Limitations of the current Microbial Identification System for identification of clinical yeast isolates. J. Clin. Microbiol. 36:1197-1200.
14. Kellogg, J. A., D. A. Bankert, and V. Chaturvedi. 1999. Unpublished data.
15. Merz, W. G., J. E. Karp, D. Schron, and R. Saral. 1986. Increased incidence of fungemia caused by Candida krusei. J. Clin. Microbiol. 24:581-584.
16. Meyer, R. D. 1992. Current role of therapy with amphotericin B. Clin. Infect. Dis. 14(Suppl.):154-160.
17. Osterhout, G. J., V. H. Shull, and J. D. Dick. 1991. Identification of clinical isolates of gram-negative nonfermentative bacteria by an automated cellular fatty acid identification system. J. Clin. Microbiol. 29:1822-1830.
18. Paisley, R. (MIDI, Inc.) 1998. Personal communication.
19. Pfaller, M. A., T. Preston, M. Bale, F. P. Koontz, and B. A. Body. 1988. Comparison of the Quantum II, API Yeast Ident, and AutoMicrobic systems for identification of clinical yeast isolates. J. Clin. Microbiol. 26:2054-2058.
20. Pinjon, E., D. Sullivan, I. Salkin, D. Shanley, and D. Coleman. 1998. Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans. J. Clin. Microbiol. 36:2093-2095.
21. Ramani, R., S. Gromadzki, D. H. Pincus, I. F. Salkin, and V. Chaturvedi. 1998. Efficacy of API 20C and ID 32C systems for identification of common and rare clinical yeast isolates. J. Clin. Microbiol. 36:3396-3398.
22. Remel. 1993. Technical information. Sabouraud dextrose agar pH 5.6. TI no. 1768-A. Remel, Lenexa, Kans.
23. Sasser, M. 1991. MIS whole cell fatty acid analysis by gas chromatography. Microbial ID, Inc., Newark, Del.
24. Warren, N. G., and K. C. Hazen. 1995. Candida, Cryptococcus, and other yeasts of medical importance, p. 723-737. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
25. Wassertheil-Smoller, S. 1990. Biostatistics and epidemiology. A primer for health professionals, p. 40-41. Springer-Verlag, New York, N.Y.
26. Wingard, J. R. 1995. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin. Infect. Dis. 20:115-125.